医薬品の開発に
「実りある」
患者・市民参画を育てる
Multi-stakeholder Co-creation
Social co-creation with patients and public
Inclusive and sustainable participation from diverse backgrounds
Equitable and reciprocal benefits
Ongoing opportunities for mutual learning – not just receiving support or making requests
Concrete actions
Robust planning to return value to society
Clinical Trial Ambassador Project
Empirical research 'Using PED as Evidence'
A pilot case study 'Building PED using metaverse'
Patient-focused clinical trial ecosystem
Supporting citizen science
Interdisciplinary Approach to Science
Empirical research activities that foster patient and public involvement (PPI)
A Focus on Societal Implementation
Consultation to implement PPI
We offer consultations on PPI
in medicines development and clinical research.
Our team—representing various professional backgrounds—works with
companies, researchers, healthcare providers, and patient groups
to help put PPI into practice.
Participation in PFMD's initiative
Patient engagement and patient experience data
Patient engagement in health technology assessment
Global clinical trials ecosystem
Co-hosted by 1st PEOF+ Asia Pacific in Manila in 2026.
A Global Perspective
Systematizing PPI through international collaboration
Our Milestones
2020 In Austria, Boehringer Ingelheim and European Patients' Academy on Therapeutic Innovation (EUPATI) jointly launched the Clinical Trial Ambassador Project. The first training sessioin for patient organisations was delivered.
2021 Bringing Patient Education to Japan - Boehringer Ingelheim, patient organisations, and researchers comes together to design a Japanese version of the Clinical Trial Ambassador Project.
2022 Collaboration beyond Organizational Boundaries - Volunteers from pharmaceutical companies, patient organisations, and academia worked togather to deliver the first Clinical Trial Ambassador Training program in Japan. Six patient representatives completed the training and became Clinical Trial Ambassadors.
2024 Expanding Innovation for Society - To strengthen the public value, transparency, and credibility of the Project, its governing body was established as nonprofit. On April 25, YORIAILab was officially founded.
2025 Building a Co-creation Community - To further advance PPI in healthcare and medicines development, YORIAILab expanded its activities beyond the Clinical Trial Ambassador Project, strengthening education, partnerships, and research. By August 2026, more than 60 patients and members of the public had completed the training program and becoming contributors to a growing co-creation community.
Highlights
Latest information on events and resources ➡️
Clinical Trial Ecosystem
To advance a healthcare ecosystem shaped by patient perspectives, we contribute to discussions on the implementation of Decentralized Clinical Trials (DCTs). We organize standing workshops with Clinical Trial Ambassadors to explore the future of DCTs from the patient perspective. We also collaborate with medical institutions to support the implementation of PPI in clinical research.
Events & Projects
Do you know about PPIs?
PPI＝Patient and Public Involvement
 |  |  |
|---|---|---|
 |  |
パネル絵：グラフィックレコーダー吉川観奈さん（http://bluebeeink.com/）
News
Latest information on events and resources ➡️
2026.9.15 [Latest]
We held the 24th Lunchtime Short Seminar. Under the title “Understanding the Mind, Changing the Mind – What Are Mental Disorders?”, we welcomed Soji Tsuboi from Okehazama Hospital as our speaker. Speaking from his perspective as a clinical research coordinator at a psychiatric hospital, Mr. Tsuboi shared how gaining a little understanding of mental disorders may change the way we act from tomorrow.
2026.9.15 [Latest]
We held the 24th Lunchtime Short Seminar. Under the title “Understanding the Mind, Changing the Mind – What Are Mental Disorders?”, we welcomed Soji Tsuboi from Okehazama Hospital as our speaker. Speaking from his perspective as a clinical research coordinator at a psychiatric hospital, Mr. Tsuboi shared how gaining a little understanding of mental disorders may change the way we act from tomorrow.
2026.9.5
We have changed YORIAILab’s domain from yoriailab.com to yoriailab.org. This change was made to more clearly communicate that YORIAILab is an organisation engaged in non-profit social co-creation activities. Please note that if you access yoriailab.com as before, you will automatically be redirected to yoriailab.org, so no special action is required. We sincerely appreciate your continued support of YORIAILab.
2026.9.5
We have changed YORIAILab’s domain from yoriailab.com to yoriailab.org. This change was made to more clearly communicate that YORIAILab is an organisation engaged in non-profit social co-creation activities. Please note that if you access yoriailab.com as before, you will automatically be redirected to yoriailab.org, so no special action is required. We sincerely appreciate your continued support of YORIAILab.
2026.9.5
We have changed YORIAILab’s domain from yoriailab.com to yoriailab.org. This change was made to more clearly communicate that YORIAILab is an organisation engaged in non-profit social co-creation activities. Please note that if you access yoriailab.com as before, you will automatically be redirected to yoriailab.org, so no special action is required. We sincerely appreciate your continued support of YORIAILab.
2026.9.5
We have changed YORIAILab’s domain from yoriailab.com to yoriailab.org. This change was made to more clearly communicate that YORIAILab is an organisation engaged in non-profit social co-creation activities. Please note that if you access yoriailab.com as before, you will automatically be redirected to yoriailab.org, so no special action is required. We sincerely appreciate your continued support of YORIAILab.
2026.9.5
We have changed YORIAILab’s domain from yoriailab.com to yoriailab.org. This change was made to more clearly communicate that YORIAILab is an organisation engaged in non-profit social co-creation activities. Please note that if you access yoriailab.com as before, you will automatically be redirected to yoriailab.org, so no special action is required. We sincerely appreciate your continued support of YORIAILab.
2026.9.5
We have changed YORIAILab’s domain from yoriailab.com to yoriailab.org. This change was made to more clearly communicate that YORIAILab is an organisation engaged in non-profit social co-creation activities. Please note that if you access yoriailab.com as before, you will automatically be redirected to yoriailab.org, so no special action is required. We sincerely appreciate your continued support of YORIAILab.
2026.9.5
We have changed YORIAILab’s domain from yoriailab.com to yoriailab.org. This change was made to more clearly communicate that YORIAILab is an organisation engaged in non-profit social co-creation activities. Please note that if you access yoriailab.com as before, you will automatically be redirected to yoriailab.org, so no special action is required. We sincerely appreciate your continued support of YORIAILab.
2026.9.1
We have revised our Membership Fee Regulations. In addition to the existing membership categories, we have introduced a new Student Membership category. With an annual membership fee of JPY 1,000, student members can also join the YORIAILab Steering Committee. As a special benefit for our interns, they can continue to enjoy the same benefits as Special Members at the Student Member fee for three years after graduating from school.
We look forward to welcoming many students to YORIAILab.
Public consultation
Public comment collection on new systems and guidelines regarding patient and public involvement
There are currently no open public consultations.
If you have any questions, please contact us here: ✉ nobutaka.yagi@yoriailab.com
